163 related articles for article (PubMed ID: 18162265)
1. Protective immune response in mice vaccinated with a recombinant adenovirus containing capsid precursor polypeptide P1, nonstructural protein 2A and 3C protease genes (P12A3C) of encephalomyocarditis virus.
Chen Z; Guo X; Ge X; Jia H; Yang H
Vaccine; 2008 Jan; 26(4):573-80. PubMed ID: 18162265
[TBL] [Abstract][Full Text] [Related]
2. A Recombinant Adenovirus Expressing P12A and 3C Protein of the Type O Foot-and-Mouth Disease Virus Stimulates Systemic and Mucosal Immune Responses in Mice.
Xie Y; Gao P; Li Z
Biomed Res Int; 2016; 2016():7849203. PubMed ID: 27478836
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of VP1-specific immune responses and protection against EMCV-K challenge by co-delivery of IL-12 DNA with VP1 DNA vaccine.
Suh YS; Ha SJ; Lee CH; Sin JI; Sung YC
Vaccine; 2001 Feb; 19(15-16):1891-8. PubMed ID: 11228358
[TBL] [Abstract][Full Text] [Related]
4. Development of replication-defective adenovirus serotype 5 containing the capsid and 3C protease coding regions of foot-and-mouth disease virus as a vaccine candidate.
Mayr GA; Chinsangaram J; Grubman MJ
Virology; 1999 Oct; 263(2):496-506. PubMed ID: 10544121
[TBL] [Abstract][Full Text] [Related]
5. Induction of a protective response in swine vaccinated with DNA encoding foot-and-mouth disease virus empty capsid proteins and the 3D RNA polymerase.
Cedillo-Barrón L; Foster-Cuevas M; Belsham GJ; Lefèvre F; Parkhouse RME
J Gen Virol; 2001 Jul; 82(Pt 7):1713-1724. PubMed ID: 11413383
[TBL] [Abstract][Full Text] [Related]
6. Protective efficacy of adenovirus-mediated small interfering RNAs against encephalomyocarditis virus challenge in mice.
Bai J; Jiang K; Zhang L; Wang X; Wang X; Li Y; Jiang P
J Virol Methods; 2012 Nov; 185(2):204-12. PubMed ID: 22790206
[TBL] [Abstract][Full Text] [Related]
7. Comparative studies of the capsid precursor polypeptide P1 and the capsid protein VP1 cDNA vectors for DNA vaccination against foot-and-mouth disease virus.
Yang NS; Wang JH; Lin KF; Wang CY; Kim SA; Yang YL; Jong MH; Kuo TY; Lai SS; Cheng RH; Chan MT; Liang SM
J Gene Med; 2005 Jun; 7(6):708-17. PubMed ID: 15693054
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity of plasmids encoding P12A and 3C of FMDV and swine IL-18.
Mingxiao M; Ningyi J; Juan LH; Min Z; Guoshun S; Guangze Z; Huijun L; Xiaowei H; Minglan J; Xu L; Haili M; Yue J; Gefen Y; Kuoshi J
Antiviral Res; 2007 Oct; 76(1):59-67. PubMed ID: 17606304
[TBL] [Abstract][Full Text] [Related]
9. Protective immunity against heterologous challenge with encephalomyocarditis virus by VP1 DNA vaccination: effect of coinjection with a granulocyte-macrophage colony stimulating factor gene.
Sin JI; Sung JH; Suh YS; Lee AH; Chung JH; Sung YC
Vaccine; 1997 Dec; 15(17-18):1827-33. PubMed ID: 9413089
[TBL] [Abstract][Full Text] [Related]
10. Immune responses and expression of the virus-like particle antigen of the porcine encephalomyocarditis virus.
Jeoung HY; Lee WH; Jeong W; Ko YJ; Choi CU; An DJ
Res Vet Sci; 2010 Oct; 89(2):295-300. PubMed ID: 20378136
[TBL] [Abstract][Full Text] [Related]
11. Recombinant adenovirus co-expressing capsid proteins of two serotypes of foot-and-mouth disease virus (FMDV): in vitro characterization and induction of neutralizing antibodies against FMDV in swine.
Wu Q; Moraes MP; Grubman MJ
Virus Res; 2003 Jun; 93(2):211-9. PubMed ID: 12782369
[TBL] [Abstract][Full Text] [Related]
12. Recombinant pseudorabies virus expressing P12A and 3C of FMDV can partially protect piglets against FMDV challenge.
Zhang K; Huang J; Wang Q; He Y; Xu Z; Xiang M; Wu B; Chen H
Res Vet Sci; 2011 Aug; 91(1):90-94. PubMed ID: 20947111
[TBL] [Abstract][Full Text] [Related]
13. Antibody response in mice inoculated with DNA expressing foot-and-mouth disease virus capsid proteins.
Chinsangaram J; Beard C; Mason PW; Zellner MK; Ward G; Grubman MJ
J Virol; 1998 May; 72(5):4454-7. PubMed ID: 9557740
[TBL] [Abstract][Full Text] [Related]
14. Comparison of immune responses to different foot-and-mouth disease genetically engineered vaccines in guinea pigs.
Yao Q; Qian P; Huang Q; Cao Y; Chen H
J Virol Methods; 2008 Jan; 147(1):143-50. PubMed ID: 17963851
[TBL] [Abstract][Full Text] [Related]
15. Intranasal delivery of cationic PLGA nano/microparticles-loaded FMDV DNA vaccine encoding IL-6 elicited protective immunity against FMDV challenge.
Wang G; Pan L; Zhang Y; Wang Y; Zhang Z; Lü J; Zhou P; Fang Y; Jiang S
PLoS One; 2011; 6(11):e27605. PubMed ID: 22110686
[TBL] [Abstract][Full Text] [Related]
16. Novel expression of immunogenic foot-and-mouth disease virus-like particles in Nicotiana benthamiana.
Veerapen VP; van Zyl AR; Wigdorovitz A; Rybicki EP; Meyers AE
Virus Res; 2018 Jan; 244():213-217. PubMed ID: 29196195
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity of the capsid precursor and a nine-amino-acid site-directed mutant of the 3C protease of foot-and-mouth disease virus coexpressed by a recombinant goatpox virus.
Ma W; Wei J; Wei Y; Guo H; Jin Y; Xue Y; Wang Y; Yi Z; Liu L; Huang J; Wang L
Arch Virol; 2014 Jul; 159(7):1715-22. PubMed ID: 24473707
[TBL] [Abstract][Full Text] [Related]
18. Construction and immunogenicity of a recombinant fowlpox virus containing the capsid and 3C protease coding regions of foot-and-mouth disease virus.
Zheng M; Jin N; Zhang H; Jin M; Lu H; Ma M; Li C; Yin G; Wang R; Liu Q
J Virol Methods; 2006 Sep; 136(1-2):230-7. PubMed ID: 16780963
[TBL] [Abstract][Full Text] [Related]
19. Protection of guinea pigs and swine by a recombinant adenovirus expressing O serotype of foot-and-mouth disease virus whole capsid and 3C protease.
Lu Z; Bao H; Cao Y; Sun P; Guo J; Li P; Bai X; Chen Y; Xie B; Li D; Liu Z; Xie Q
Vaccine; 2008 Dec; 26 Suppl 6():G48-53. PubMed ID: 19178894
[TBL] [Abstract][Full Text] [Related]
20. Effect of foot-and-mouth disease virus capsid precursor protein and 3C protease expression on bovine herpesvirus 1 replication.
Klopfleisch C; Minh LQ; Giesow K; Curry S; Keil GM
Arch Virol; 2010 May; 155(5):723-31. PubMed ID: 20333533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
